Page last updated: 2024-10-24

regulation of gliogenesis

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of gliogenesis, the formation of mature glia. [GOC:ef]

Gliogenesis, the process of generating new glial cells, is tightly regulated by a complex interplay of intrinsic and extrinsic factors. These factors include transcription factors, signaling pathways, and environmental cues, all of which work together to control the timing, location, and type of glial cells generated.

**Intrinsic Factors:**

* **Transcription factors:** Specific transcription factors like Sox2, Pax6, and Olig2 play critical roles in specifying glial cell fate. They bind to specific DNA sequences within genes, activating or repressing their expression to drive glial cell differentiation.
* **Epigenetic modifications:** Modifications to DNA and histone proteins can alter gene expression, impacting glial cell development. These modifications include methylation, acetylation, and phosphorylation, which can either promote or suppress glial cell differentiation.

**Extrinsic Factors:**

* **Signaling pathways:** Several signaling pathways, including the Notch, Wnt, and Shh pathways, play crucial roles in regulating gliogenesis. These pathways are activated by secreted ligands and involve a cascade of intracellular events that ultimately alter gene expression, influencing cell fate decisions.
* **Environmental cues:** Environmental cues such as oxygen levels, nutrient availability, and the presence of other cell types can influence gliogenesis. For example, the presence of neurons can trigger glial cell differentiation, while hypoxia can promote the formation of astrocytes.

**Regulation of Glial Cell Types:**

* **Astrocytes:** Astrocytes, the most abundant glial cell type, are involved in numerous functions, including supporting neurons, regulating the blood-brain barrier, and maintaining the extracellular environment. Their development is regulated by a complex interplay of transcription factors like GFAP, signaling pathways like the Notch pathway, and environmental cues like neuronal activity.
* **Oligodendrocytes:** Oligodendrocytes are responsible for myelinating axons, enhancing the speed of nerve impulse conduction. Their differentiation is controlled by transcription factors like Olig1 and Olig2, signaling pathways like the Shh pathway, and environmental cues like the presence of axons.
* **Microglia:** Microglia, the resident immune cells of the central nervous system, are involved in immune surveillance and response. Their development is regulated by factors like PU.1, CSF1R, and signaling pathways like the TGF-beta pathway.

**Dysregulation of Gliogenesis:**

* **Neurological disorders:** Dysregulation of gliogenesis can contribute to the development of various neurological disorders, including neurodegenerative diseases, brain tumors, and neurodevelopmental disorders. For example, aberrant glial cell proliferation can contribute to tumor formation, while impaired oligodendrocyte differentiation can lead to demyelination in diseases like multiple sclerosis.

**Therapeutic Implications:**

* **Regenerative medicine:** Understanding the mechanisms regulating gliogenesis has significant therapeutic implications for regenerative medicine. Strategies aimed at promoting glial cell differentiation or transplantation could be used to treat neurological disorders characterized by glial cell loss or dysfunction.

**Summary:**

Gliogenesis is a highly regulated process involving a complex interplay of intrinsic and extrinsic factors. Understanding the molecular mechanisms underlying glial cell development is essential for developing therapeutic strategies to treat neurological disorders and advance regenerative medicine.'
```"

Proteins (1)

ProteinDefinitionTaxonomy
Histone-lysine N-methyltransferase EZH2A histone-lysine N-methyltransferase EZH2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15910]Homo sapiens (human)

Compounds (10)

CompoundDefinitionClassesRoles
3-deazaneplanocin3-deazaneplanocin: S-adenosylhomocysteine hydrolase antagonist
tanshinonetanshinone: from root of Salvia miltiorrhiza Bunge; RN given refers to tanshinone I; cardioprotective agent and neuroprotective agentabietane diterpenoidanticoronaviral agent
przewaquinone dprzewaquinone D: isolated from root of Salvia przewalskii; structure given in first source; RN given refers to the trans- isomer, przewaquinone D
tanshinone ii atashinone IIA: a cardiovascular agent with antineoplastic activity; isolated from Salvia miltiorrhiza; structure in first sourceabietane diterpenoid
s-adenosylhomocysteineS-adenosyl-L-homocysteine : An organic sulfide that is the S-adenosyl derivative of L-homocysteine.

S-Adenosylhomocysteine: 5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.
adenosines;
amino acid zwitterion;
homocysteine derivative;
homocysteines;
organic sulfide
cofactor;
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor;
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor;
epitope;
fundamental metabolite
epz005687EPZ005687: inhibits EZH2 protein; structure in first sourceindazoles
epz-6438tazemetostat: a histone methyltransferase EZH2 inhibitor with antineoplastic activity
gsk-2816126GSK-2816126: inhibits EZH2 methyltransferase; structure in first sourcepiperazines;
pyridines
gsk343GSK343 : A member of the class of indazoles that is 1-isopropyl-1H-indazole-4-carboxamide in which the nitrogen of the carboxamide group is substituted by a (6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl group and in which the indazole ring is substituted at position 6 by a 2-(4-methylpiperazin-1-yl)pyridin-4-yl group. A highly potent and selective EZH2 inhibitor (IC50 = 4 nM).

GSK343: an EZH2 methyltransferase inhibitor
aminopyridine;
indazoles;
N-alkylpiperazine;
N-arylpiperazine;
pyridone;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor
1-[(1R)-1-(1-ethylsulfonyl-4-piperidinyl)ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-3-indolecarboxamide(R)-1-(1-(1-(ethylsulfonyl)piperidin-4-yl)ethyl)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1H-indole-3-carboxamide: EZH2 inhibitorindolecarboxamide